Market Diagnostics International (MDxI) is a leading provider of custom and syndicated market information for medical and scientific technologies. Founded in 1988, MDxI helps clients develop and market medical and scientific technologies, including in vitro diagnostics, life science research applications and analytical systems, medical devices and supplies, diagnostic imaging equipment, and therapeutics.

We provide powerful, individualized business solutions grounded in advanced market research design and statistical analysis, and based on detailed industry knowledge. MDxI’s consulting and research services rely on an expanding proprietary database of professionals in hospitals, physician offices, clinical reference laboratories, blood banks and life science research laboratories.

We’ve built our reputation with the leading companies in the field of medical and scientific technology by providing state of the art research and market analysis, and by understanding the clinical and scientific environment, as well as practical realities of these industries. We provide invaluable information to aid product development and market assessment in fields such as:

In Vitro Diagnostics
Laboratory: Clinical Chemistry, Molecular Diagnostics/Human Genetics, Infectious Disease, Microbiology, Immunoassay, Drugs of Abuse (SAMHSA and FDA markets), Hematology/ Coagulation, Immunohematology, Blood Processing.
Point of Care: Diabetes, Drugs of Abuse, Infectious Disease, Coagulation, and Cardiology

Life Science Research
Electrophoresis, Protein Purification, Real-Time PCR, Gene Sequencing

Pharmaceuticals
Biomarkers: Endocrinology, Oncology, Infectious Disease, and Cardiology

Medical Devices
Surgical devices (Endoscopy, Orthopedics, Cardiology), Robotics, Surgical Implants, Ablation, and Vision Care

Our vast experience ensures that we are an effective partner from day one, turning research into results.